Public & Societal Benefit
(W20Z)
990 on File
DRUG STRATEGIES
Financial strength (30%)
78/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$4K
Total Revenue
$358K
Total Expenses
$1.7M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
81.8%
Fundraising Efficiency
N/A
Operating Reserve
55.55x
Liability-to-Asset
0.9%
Revenue Diversification
93.1%
Executive Compensation
$86K
Compared with Peers
FY 2025
Compared with 731 similar organizations
(United States, Public & Societal Benefit, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
81.8% | 87.1% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.1% | 9.9% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
8.1% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
55.6 mo | 9.2 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.9% | 0.4% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.1% | 96.5% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-99.8% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-4.5% | 10.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-9748.9% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $4K | $358K | $1.7M | 81.8% | 2 |
| 2024 | $1.9M | $375K | $1.9M | 75.9% | 1 |
| 2023 | $73K | $238K | $350K | 77.2% | 1 |
| 2022 | $182K | $284K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.